Clinical Trial Results: Safety and Efficacy of MK-1200 in Participants With Advanced Solid Tumors (MK-1200-002) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial results for MK-1200 in participants with advanced solid tumors across Phase 1 and Phase 2 are posted; study completed with safety and efficacy da…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• MK-1200

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Advanced Solid Tumors | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2026-06-05